{"id":514252,"date":"2021-07-17T09:03:03","date_gmt":"2021-07-17T13:03:03","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\/"},"modified":"2021-07-17T09:03:03","modified_gmt":"2021-07-17T13:03:03","slug":"athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\/","title":{"rendered":"ATHIRA SHAREHOLDERS: August 24, 2021 Filing Deadline in Class Action \u2013 Contact Lieff Cabraser"},"content":{"rendered":"<p>        <!--.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p><b>ATHIRA SHAREHOLDERS: August 24, 2021 Filing Deadline in Class Action \u2013 Contact Lieff Cabraser<\/b><\/p>\n<p>SAN FRANCISCO&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nThe law firm of Lieff Cabraser Heimann &amp; Bernstein, LLP announces that <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.lieffcabraser.com%2Fsecurities%2Fathira%2F&amp;esheet=52461664&amp;newsitemid=20210717005005&amp;lan=en-US&amp;anchor=class+action+litigation+has+been+filed+on+behalf+of+investors+who+purchased+or+otherwise+acquired+the+securities+of+Athira+Pharma%2C+Inc.&amp;index=1&amp;md5=5bcbfaefa7d16e4e4cd869b943d09507\">class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Athira Pharma, Inc.<\/a> (\u201cAthira\u201d or the \u201cCompany\u201d) (Nasdaq: ATHA) between September 18, 2020 and June 17, 2021 (the \u201cClass Period\u201d), including Athira common stock purchased pursuant or traceable to the registration statement and prospectus issued in connection with the Company\u2019s initial public offering (\u201cIPO\u201d) in September 2020.\n<\/p>\n<p>\nIf you purchased or otherwise acquired Athira securities during the Class Period and\/or in the IPO, you may move the Court for appointment as lead plaintiff by no later than August 24, 2021. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. Your share of any recovery in the actions will not be affected by your decision of whether to seek appointment as lead plaintiff. You may retain Lieff Cabraser, or other attorneys, as your counsel in the action.\n<\/p>\n<p><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.lieffcabraser.com%2Fsecurities%2Fathira%2F&amp;esheet=52461664&amp;newsitemid=20210717005005&amp;lan=en-US&amp;anchor=Athira+investors+who+wish+to+learn+more+about+the+litigation+and+how+to+seek+appointment+as+lead+plaintiff+should+click+here&amp;index=2&amp;md5=0684013dcfb7db61883eb93b1874ab8a\">Athira investors who wish to learn more about the litigation and how to seek appointment as lead plaintiff should click here<\/a> or contact Sharon M. Lee of Lieff Cabraser toll-free at 1-800-541-7358.\n<\/p>\n<p><span class=\"bwuline\">Background on the Athira Securities Class Litigation<\/span><\/p>\n<p>\nAthira, headquartered in Bothell, Washington, is a clinical-stage biopharmaceutical company focused on the development of molecular technology in the treatment of neurological diseases, including Alzheimer\u2019s disease. In September 2020, Athira completed its IPO by issuing and selling approximately 13 million shares of common stock at $17.00 per share, for net proceeds of approximately $186 million.\n<\/p>\n<p>\nThe actions allege that, throughout the Class Period, defendants made materially false and misleading statements and\/or omitted to state material adverse facts regarding the Company\u2019s business, operations, and prospects. Specifically, the actions allege that defendants failed to disclose to investors that the doctoral research conducted by Athira\u2019s Chief Executive Officer and President, defendant Leen Kawas contained improperly altered images and constituted potential research misconduct. Kawas\u2019s research reportedly was foundational to Athira\u2019s efforts to develop treatments for Alzheimer\u2019s disease and cited in a patent licensed by Athira.\n<\/p>\n<p>\nOn June 17, 2021, after markets closed, Athira announced that Kawas was placed on temporary leave pending an investigation by a special committee into \u201cactions stemming from doctoral research Dr. Kawas conducted while at Washington State University.\u201d The same day, the scientific publication <i>STAT <\/i>reported that the investigation involves allegedly altered images appearing in four papers for which Kawas was the lead author. According to <i>STAT<\/i>, Kawas\u2019s research papers \u201care foundational to Athira\u2019s efforts to treat Alzheimer\u2019s\u201d and her \u201cdoctoral work laid the biological groundwork that Athira continues to use in their approach to treating Alzheimer\u2019s.\u201d According to an investment analyst, the investigation could have \u201cclear negative implications for how we\/investors view the asset, and\/or management credibility.\u201d On this news, the price of Athira common stock fell $7.09 per share, or 38.9%, from a closing price of $18.24 on June 17, 2021, to close at $11.15 per share on June 18, 2021, on heavy trading volume.\n<\/p>\n<p><b>About Lieff Cabraser<\/b><\/p>\n<p>\nLieff Cabraser Heimann &amp; Bernstein, LLP, with offices in San Francisco, New York, Nashville, and Munich is an internationally recognized law firm committed to advancing the rights of investors and promoting corporate responsibility worldwide.\n<\/p>\n<p><i>The National Law Journal<\/i> has recognized Lieff Cabraser as one of the nation\u2019s top plaintiffs\u2019 law firms for fourteen years. In compiling the list, the <i>National Law Journal<\/i> examines recent verdicts and settlements and looked for firms \u201crepresenting the best qualities of the plaintiffs\u2019 bar and that demonstrated unusual dedication and creativity.\u201d <i>Law360<\/i> has selected Lieff Cabraser as one of the Top 50 law firms nationwide for litigation, highlighting our firm\u2019s \u201claser focus\u201d and noting that our firm routinely finds itself \u201cfacing off against some of the largest and strongest defense law firms in the world.\u201d <i>Benchmark Litigation<\/i> has named Lieff Cabraser one of the \u201cTop 10 Plaintiffs\u2019 Firms in America.\u201d\n<\/p>\n<p>\nFor more information about Lieff Cabraser and the firm\u2019s representation of investors, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.lieffcabraser.com%2F&amp;esheet=52461664&amp;newsitemid=20210717005005&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.lieffcabraser.com%2F&amp;index=3&amp;md5=523be25824910e1b1771655476eb19de\">https:\/\/www.lieffcabraser.com\/<\/a>.\n<\/p>\n<p>\nThis press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210717005005r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210717005005\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210717005005\/en\/<\/a><\/span><\/p>\n<p>\nSharon M. Lee<br \/>\n<br \/>Lieff Cabraser Heimann &amp; Bernstein, LLP<br \/>\n<br \/>Telephone: 1-800-541-7358\n<\/p>\n<p><b>KEYWORDS:<\/b> United States North America California<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Legal Professional Services<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210717005005\/en\/353764\/3\/Lieff_Cabraser_logo.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>ATHIRA SHAREHOLDERS: August 24, 2021 Filing Deadline in Class Action \u2013 Contact Lieff Cabraser SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211; The law firm of Lieff Cabraser Heimann &amp; Bernstein, LLP announces that class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Athira Pharma, Inc. (\u201cAthira\u201d or the \u201cCompany\u201d) (Nasdaq: ATHA) between September 18, 2020 and June 17, 2021 (the \u201cClass Period\u201d), including Athira common stock purchased pursuant or traceable to the registration statement and prospectus issued in connection with the Company\u2019s initial public offering (\u201cIPO\u201d) in September 2020. If you purchased or otherwise acquired Athira securities during the Class Period and\/or in the IPO, you may move the Court for appointment as lead plaintiff &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ATHIRA SHAREHOLDERS: August 24, 2021 Filing Deadline in Class Action \u2013 Contact Lieff Cabraser&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-514252","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ATHIRA SHAREHOLDERS: August 24, 2021 Filing Deadline in Class Action \u2013 Contact Lieff Cabraser - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ATHIRA SHAREHOLDERS: August 24, 2021 Filing Deadline in Class Action \u2013 Contact Lieff Cabraser - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ATHIRA SHAREHOLDERS: August 24, 2021 Filing Deadline in Class Action \u2013 Contact Lieff Cabraser SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211; The law firm of Lieff Cabraser Heimann &amp; Bernstein, LLP announces that class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Athira Pharma, Inc. (\u201cAthira\u201d or the \u201cCompany\u201d) (Nasdaq: ATHA) between September 18, 2020 and June 17, 2021 (the \u201cClass Period\u201d), including Athira common stock purchased pursuant or traceable to the registration statement and prospectus issued in connection with the Company\u2019s initial public offering (\u201cIPO\u201d) in September 2020. If you purchased or otherwise acquired Athira securities during the Class Period and\/or in the IPO, you may move the Court for appointment as lead plaintiff &hellip; Continue reading &quot;ATHIRA SHAREHOLDERS: August 24, 2021 Filing Deadline in Class Action \u2013 Contact Lieff Cabraser&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-17T13:03:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210717005005r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ATHIRA SHAREHOLDERS: August 24, 2021 Filing Deadline in Class Action \u2013 Contact Lieff Cabraser\",\"datePublished\":\"2021-07-17T13:03:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\\\/\"},\"wordCount\":749,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210717005005r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\\\/\",\"name\":\"ATHIRA SHAREHOLDERS: August 24, 2021 Filing Deadline in Class Action \u2013 Contact Lieff Cabraser - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210717005005r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-07-17T13:03:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210717005005r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210717005005r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ATHIRA SHAREHOLDERS: August 24, 2021 Filing Deadline in Class Action \u2013 Contact Lieff Cabraser\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ATHIRA SHAREHOLDERS: August 24, 2021 Filing Deadline in Class Action \u2013 Contact Lieff Cabraser - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\/","og_locale":"en_US","og_type":"article","og_title":"ATHIRA SHAREHOLDERS: August 24, 2021 Filing Deadline in Class Action \u2013 Contact Lieff Cabraser - Market Newsdesk","og_description":"ATHIRA SHAREHOLDERS: August 24, 2021 Filing Deadline in Class Action \u2013 Contact Lieff Cabraser SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211; The law firm of Lieff Cabraser Heimann &amp; Bernstein, LLP announces that class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Athira Pharma, Inc. (\u201cAthira\u201d or the \u201cCompany\u201d) (Nasdaq: ATHA) between September 18, 2020 and June 17, 2021 (the \u201cClass Period\u201d), including Athira common stock purchased pursuant or traceable to the registration statement and prospectus issued in connection with the Company\u2019s initial public offering (\u201cIPO\u201d) in September 2020. If you purchased or otherwise acquired Athira securities during the Class Period and\/or in the IPO, you may move the Court for appointment as lead plaintiff &hellip; Continue reading \"ATHIRA SHAREHOLDERS: August 24, 2021 Filing Deadline in Class Action \u2013 Contact Lieff Cabraser\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-17T13:03:03+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210717005005r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ATHIRA SHAREHOLDERS: August 24, 2021 Filing Deadline in Class Action \u2013 Contact Lieff Cabraser","datePublished":"2021-07-17T13:03:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\/"},"wordCount":749,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210717005005r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\/","name":"ATHIRA SHAREHOLDERS: August 24, 2021 Filing Deadline in Class Action \u2013 Contact Lieff Cabraser - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210717005005r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-07-17T13:03:03+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210717005005r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210717005005r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-shareholders-august-24-2021-filing-deadline-in-class-action-contact-lieff-cabraser\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ATHIRA SHAREHOLDERS: August 24, 2021 Filing Deadline in Class Action \u2013 Contact Lieff Cabraser"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/514252","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=514252"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/514252\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=514252"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=514252"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=514252"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}